CR7956A - Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos - Google Patents
Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismosInfo
- Publication number
- CR7956A CR7956A CR7956A CR7956A CR7956A CR 7956 A CR7956 A CR 7956A CR 7956 A CR7956 A CR 7956A CR 7956 A CR7956 A CR 7956A CR 7956 A CR7956 A CR 7956A
- Authority
- CR
- Costa Rica
- Prior art keywords
- indolona
- oxazolidinones
- preparation
- same
- pharmaceutical compositions
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion provee agentes antibacteriales de la formula (I) y derivados de su preparacion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44973403P | 2003-02-24 | 2003-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7956A true CR7956A (es) | 2005-12-01 |
Family
ID=32908714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7956A CR7956A (es) | 2003-02-24 | 2005-08-22 | Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7012088B2 (es) |
| EP (1) | EP1599470A1 (es) |
| JP (1) | JP3887396B2 (es) |
| KR (1) | KR100701226B1 (es) |
| CN (1) | CN100349892C (es) |
| AP (1) | AP2005003375A0 (es) |
| AU (1) | AU2004213246A1 (es) |
| BR (1) | BRPI0406824A (es) |
| CA (1) | CA2515984A1 (es) |
| CO (1) | CO5601039A2 (es) |
| CR (1) | CR7956A (es) |
| EA (1) | EA009725B1 (es) |
| EC (1) | ECSP055980A (es) |
| GE (1) | GEP20084306B (es) |
| HR (1) | HRP20050658A2 (es) |
| IS (1) | IS7883A (es) |
| MA (1) | MA27661A1 (es) |
| MX (1) | MXPA05008960A (es) |
| NO (1) | NO20052794L (es) |
| OA (1) | OA13032A (es) |
| PL (1) | PL377428A1 (es) |
| RS (1) | RS20050649A (es) |
| TN (1) | TNSN05202A1 (es) |
| UA (1) | UA80326C2 (es) |
| WO (1) | WO2004074282A1 (es) |
| ZA (1) | ZA200505225B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| BRPI0513083A (pt) * | 2004-08-06 | 2008-04-22 | Pharmacia & Upjohn Co Llc | oxazolidinonas contendo oxindóis como agentes antibacterianos |
| AU2006231919A1 (en) * | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| EP1869029A1 (en) * | 2005-04-06 | 2007-12-26 | Pharmacia & Upjohn Company LLC | An oxindole oxazolidinone as antibacterial agent |
| RS53599B1 (sr) | 2005-05-10 | 2015-02-27 | Intermune, Inc. | Piridon derivati za modulaciju stresom aktiviranog sistema proteinskih kinaza |
| WO2007088478A1 (en) * | 2006-02-01 | 2007-08-09 | Pfizer Products Inc. | Indazole oxazolidinones as antibacterial agents |
| WO2007091147A1 (en) * | 2006-02-08 | 2007-08-16 | Pfizer Products Inc. | Oxazolidinones containing oxindoles as antibacterial agents |
| JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン， インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
| FR2948940B1 (fr) * | 2009-08-04 | 2011-07-22 | Servier Lab | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP5685384B2 (ja) * | 2010-03-29 | 2015-03-18 | 公益財団法人相模中央化学研究所 | ３，３−ジフルオロ−２，３−ジヒドロインドール−２−オン誘導体の製造方法 |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| JP6263124B2 (ja) * | 2012-10-17 | 2018-01-17 | 国立大学法人 岡山大学 | 化合物、その互変異性体、幾何異性体、乃至それらの塩、及びそれらの製造方法、抗菌剤、並びに感染症治療薬 |
| CN103193794B (zh) * | 2013-04-12 | 2016-04-06 | 中国药科大学 | 一种异吲哚酮并异噁唑类稠环化合物及其合成方法 |
| CN106459042B (zh) | 2014-04-02 | 2019-06-28 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
| CN107151225B (zh) * | 2017-06-30 | 2020-05-08 | 贵州大学 | 2-羟基吲哚类衍生物、其制备方法和用途 |
| CN113773306B (zh) * | 2021-10-29 | 2023-11-10 | 四川农业大学 | 3,3-二取代吲哚酮类化合物及其制备方法和应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225565A (en) | 1988-09-15 | 1993-07-06 | The Upjohn Company | Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones |
| WO1990002744A1 (en) | 1988-09-15 | 1990-03-22 | The Upjohn Company | In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones |
| US5164510A (en) | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| HRP960159A2 (en) | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
| DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| DE19805117A1 (de) | 1998-02-09 | 1999-08-12 | Bayer Ag | Neue Oxazolidinone mit azolhaltigen Tricyclen |
| CN1311787A (zh) | 1998-06-05 | 2001-09-05 | 阿斯特拉曾尼卡有限公司 | 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物 |
| GB9812019D0 (en) | 1998-06-05 | 1998-07-29 | Zeneca Ltd | Chemical compounds |
| GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
| AU1045300A (en) | 1998-11-17 | 2000-06-05 | Bayer Aktiengesellschaft | Novel heterocyclyl-substituted oxazolidone derivatives |
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| PE20011124A1 (es) | 2000-03-31 | 2001-10-28 | Upjohn Co | Nuevos agentes antibacterianos de benzosultam oxazolidinona |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| US8048386B2 (en) | 2002-02-25 | 2011-11-01 | Cepheid | Fluid processing and control |
| PE20030044A1 (es) | 2000-11-17 | 2003-02-09 | Upjohn Co | Isoxazolinonas biciclicas de formula i |
| US7022705B2 (en) | 2001-10-25 | 2006-04-04 | Astrazeneca Ab | Isoxazoline derivatives useful as antimicrobials |
-
2004
- 2004-01-22 US US10/762,838 patent/US7012088B2/en not_active Expired - Fee Related
- 2004-02-12 OA OA1200500233A patent/OA13032A/en unknown
- 2004-02-12 KR KR1020057015556A patent/KR100701226B1/ko not_active Expired - Fee Related
- 2004-02-12 MX MXPA05008960A patent/MXPA05008960A/es active IP Right Grant
- 2004-02-12 CN CNB2004800027371A patent/CN100349892C/zh not_active Expired - Fee Related
- 2004-02-12 HR HR20050658A patent/HRP20050658A2/hr not_active Application Discontinuation
- 2004-02-12 BR BR0406824-6A patent/BRPI0406824A/pt not_active IP Right Cessation
- 2004-02-12 AP AP2005003375A patent/AP2005003375A0/xx unknown
- 2004-02-12 EA EA200501341A patent/EA009725B1/ru not_active IP Right Cessation
- 2004-02-12 CA CA002515984A patent/CA2515984A1/en not_active Abandoned
- 2004-02-12 JP JP2005518544A patent/JP3887396B2/ja not_active Expired - Fee Related
- 2004-02-12 EP EP04710451A patent/EP1599470A1/en not_active Withdrawn
- 2004-02-12 PL PL377428A patent/PL377428A1/pl not_active Application Discontinuation
- 2004-02-12 RS YUP-2005/0649A patent/RS20050649A/sr unknown
- 2004-02-12 WO PCT/IB2004/000466 patent/WO2004074282A1/en not_active Ceased
- 2004-02-12 GE GEAP20048948A patent/GEP20084306B/en unknown
- 2004-02-12 AU AU2004213246A patent/AU2004213246A1/en not_active Abandoned
- 2004-12-02 UA UAA200509025A patent/UA80326C2/uk unknown
-
2005
- 2005-06-09 IS IS7883A patent/IS7883A/is unknown
- 2005-06-09 NO NO20052794A patent/NO20052794L/no not_active Application Discontinuation
- 2005-06-28 ZA ZA200505225A patent/ZA200505225B/en unknown
- 2005-08-19 CO CO05082195A patent/CO5601039A2/es not_active Application Discontinuation
- 2005-08-22 CR CR7956A patent/CR7956A/es unknown
- 2005-08-24 EC EC2005005980A patent/ECSP055980A/es unknown
- 2005-08-24 TN TNP2005000202A patent/TNSN05202A1/fr unknown
- 2005-08-24 MA MA28456A patent/MA27661A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1082253A1 (zh) | 2006-06-02 |
| CN1742008A (zh) | 2006-03-01 |
| AU2004213246A1 (en) | 2004-09-02 |
| RS20050649A (sr) | 2007-11-15 |
| GEP20084306B (en) | 2008-02-11 |
| MA27661A1 (fr) | 2005-12-01 |
| MXPA05008960A (es) | 2005-11-04 |
| CN100349892C (zh) | 2007-11-21 |
| NO20052794D0 (no) | 2005-06-09 |
| BRPI0406824A (pt) | 2005-12-27 |
| AP2005003375A0 (en) | 2005-09-30 |
| TNSN05202A1 (fr) | 2007-06-11 |
| KR20050102135A (ko) | 2005-10-25 |
| HRP20050658A2 (en) | 2005-12-31 |
| US20040176610A1 (en) | 2004-09-09 |
| JP2006515012A (ja) | 2006-05-18 |
| KR100701226B1 (ko) | 2007-03-29 |
| PL377428A1 (pl) | 2006-02-06 |
| WO2004074282A1 (en) | 2004-09-02 |
| CO5601039A2 (es) | 2006-01-31 |
| IS7883A (is) | 2005-06-09 |
| OA13032A (en) | 2006-11-10 |
| EA009725B1 (ru) | 2008-02-28 |
| JP3887396B2 (ja) | 2007-02-28 |
| US7012088B2 (en) | 2006-03-14 |
| UA80326C2 (en) | 2007-09-10 |
| EP1599470A1 (en) | 2005-11-30 |
| NO20052794L (no) | 2005-11-01 |
| EA200501341A1 (ru) | 2006-02-24 |
| CA2515984A1 (en) | 2004-09-02 |
| ECSP055980A (es) | 2006-01-16 |
| ZA200505225B (en) | 2006-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2002000422A (es) | Agentes antibacterianos. | |
| UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
| ECSP066643A (es) | PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2 | |
| UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| ECSP088246A (es) | Nuevos derivados de benzotiazolona | |
| UY28342A1 (es) | Nuevos compuestos | |
| CR7956A (es) | Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos | |
| ECSP045004A (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes | |
| UY28572A1 (es) | Compuestos novedosos | |
| UY30274A1 (es) | Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones | |
| UY30681A1 (es) | Compuestos de piridinamida que contienen carboxi, sales farmacéuticamente aceptables, procedimientos para la preparacion de los mismos, composiciones que los contienen y sus usos. | |
| ECSP088296A (es) | Compuestos terapéuticos | |
| HN2002000300A (es) | Nuevos derivados de piperazina | |
| CR9954A (es) | Derivados de pirazina | |
| UY30460A1 (es) | Compuestos terapéuticos | |
| PA8575601A1 (es) | Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
| UY27424A1 (es) | Agentes antidiabéticos | |
| PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
| BR0315139A (pt) | Agentes antibacterianos de tetraidroquinolina tricìclica | |
| UY29767A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
| CR9391A (es) | Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| PA8589801A1 (es) | Aminoalcoxiindoles | |
| SV2006002319A (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
| UY30356A1 (es) | Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. | |
| GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos |